Ontology highlight
ABSTRACT: Importance
Venous thromboembolism (VTE) affects 2% to 20% of recovering trauma patients, despite aggressive prophylaxis with enoxaparin. Antithrombin is a primary circulating anticoagulant and crucial component of enoxaparin thromboprophylaxis. Approximately 20% of trauma patients present with antithrombin deficiency (antithrombin activity <80%).Objective
To examine time-dependent changes in antithrombin activity, responsiveness to enoxaparin, as measured by anti-factor Xa (anti-FXa) levels, and incidence of VTE after severe trauma and to assess the association of ex vivo antithrombin supplementation with patients' sensitivity to enoxaparin prophylaxis.Design, setting, and participants
This single-center, prospective cohort study was performed at a level 1 trauma ce
SUBMITTER: Vincent LE
PROVIDER: S-EPMC9218925 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature